Slideset updated regularly to reflect the state of the COVID-19 pandemic and to include the latest data and guidance on best practices for diagnosis and management; topics include global epidemiology, screening and diagnosis, natural history and clinical presentation, disease severity, medical management, and treatment options

The COVID-19 outbreak poses a significant challenge for all countries – creating an unprecedented need for international solidarity and a coordinated global response. This COVID-19 Partners Platform has launched anew landing platform to be an enabling tool for all countries, implementing partners, donors and contributors to collaborate in the global COVID-19 response. The Partners Platform features real-time tracking to support the planning, implementation and resourcing of country preparedness and response activities

The Vaccination Demand Hub is a network of partner organizations innovating together to understand why people miss out and to improve acceptance and uptake of vaccines, to ensure that everyone everywhere is protected against vaccine preventable diseases

The new global scenario in times of COVID-19 makes it necessary to take urgent measures and assess the impacts they will have. ECLAC has built this Observatory to support review and follow-up over the medium and long terms and at the request of CELAC. The Observatory tracks the public policies that the 33 countries of the Latin America and Caribbean region are implementing to limit the impact of the COVID-19 pandemic, and offers analyses of the economic and social impacts that these policies will have at the national and sectoral levels

The Country Readiness and Delivery(CRD) workstream which is part of the ACT Accelerator and is included in the SPRP– has developed a toolbox with guidance, tools and training.

SARS-COV-2 antigen rapid diagnostic tests are an alternative option for diagnosing active SARS-CoV-2 infection through detection of viral proteins. Rapid antigen tests revolutionize the response to COVID-19 by providing accurate test results in 10 to 20 minutes instead of days, allowing tests to be done at point of care, and dramatically lowering the price of the tests. Proper training on the safe use and implementation of antigen tests is vital to ensuring quality testing. A comprehensive training package around safety, sample collection, testing, reporting and management of antigen tests can be found below. The training package includes facilitators’ guides for master trainers and trainers, training presentations, and supplementary materials to aid in the delivery of this training

Here are resources to help accredited continuing education (CE) providers develop and deliver education about the COVID-19 vaccines. If you have any questions about accreditation requirements or any aspect of accredited education related to these vaccine

Рекомендации для населения в отношении инфекции, вызванной новым коронавирусом (COVID-19)

A key component of epidemic and pandemic preparedness is ensuring systems are in place for real-time information to flow from a trusted source to the people at risk. In the absence of such information rumours can spread rapidly through social media, resulting in an INFODEMIC. EPI-WIN is the WHO Information Network for Epidemics that will provide tailored information to different audiences during a public health event. EPI-WIN seeks to give everyone access to timely, accurate, and easy-to-understand advice and information from trusted sources on public health events and outbreaks: currently the COVID-19 public health emergency